Prolonged QT syndrome is a potentially fatal heart rhythm disorder that affects the electrical activity of the heart, potentially leading to dangerous arrhythmias. Medications such as ondansetron (Zofran) and domperidone, often prescribed for nausea and gastroparesis, have been linked to acquired long QT syndrome, increasing risk for life-threatening events like syncope (fainting), palpitations, and sudden cardiac death. It is critical for patients taking these drugs to be closely monitored by healthcare providers, as symptoms can sometimes be subtle before escalating. Regular ECG screenings to measure QT intervals can help detect dangerous prolongation early. Despite some reports that doctors may downplay the severity, medical guidelines emphasize vigilance since the condition can rapidly worsen. Patients should also inform their doctors about all medications they are taking, as drug interactions can exacerbate QT prolongation. Additionally, electrolyte imbalances such as low potassium or magnesium can increase vulnerability. Lifestyle adjustments, awareness of warning signs like dizziness or fainting spells, and emergency response planning are essential. Understanding the risks of long QT syndrome linked to commonly used medications empowers patients to advocate for proper cardiac care. Consulting cardiology specialists and receiving comprehensive assessment every six months or as advised can provide peace of mind and prevent adverse outcomes. Ultimately, knowledge and proactive management are key to safely using drugs like Zofran and domperidone without compromising heart health.